Migration of CD8+ T cells into the central nervous system gives rise to highly potent anti-HIV CD4dimCD8bright T cells in a Wnt signaling-dependent manner

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 317-327

  Richards, Maureen H ^a   Narasipura, Srinivas D ^a   Seaton, Melanie S ^a   Lutgen, Victoria ^a   Al Harthi, Lena ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL THERAPY; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN; TRANSCRIPTION REGULATION; WNT SIGNALING PATHWAY; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; NONOBESE DIABETIC MOUSE; SCID MOUSE; TRANSPLANTATION; VIROLOGY; XENOGRAFT;

CD4 ANTIGEN; CD8 ANTIGEN; IL2RG PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR GAMMA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ASTROCYTES; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; HETEROGRAFTS; HIV INFECTIONS; HIV-1; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; SPLEEN; WNT SIGNALING PATHWAY;

EID: 84953309480     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501394     Document Type: Article

References (54)

1. Hickey, W. F. 1991. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1: 97-105.
2. Marcondes, M. C., T. H. Burdo, S. Sopper, S. Huitron-Resendiz, C. Lanigan, D. Watry, C. Flynn, M. Zandonatti, and H. S. Fox. 2007. Enrichment and persistence of virus-specific CTL in the brain of simian immunodeficiency virusinfected monkeys is associated with a unique cytokine environment. J. Immunol. 178: 5812-5819.
3. Marcondes, M. C., E. M. Burudi, S. Huitron-Resendiz, M. Sanchez-Alavez, D. Watry, M. Zandonatti, S. J. Henriksen, and H. S. Fox. 2001. Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J. Immunol. 167: 5429-5438.
4. + T cells maintain suppression of simian immunodeficiency virus in the central nervous system. J. Infect. Dis. 211: 40-44.
5. + cells in simian immunodeficiency virus infection. AIDS 17: 1605-1611.
6. McCrossan, M., M. Marsden, F. W. Carnie, S. Minnis, B. Hansoti, I. C. Anthony, R. P. Brettle, J. E. Bell, and P. Simmonds. 2006. An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 129: 503-516.
7. + cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J. Neurovirol. 9: 36-44.
8. Petito, C. K., J. E. Torres-Muñoz, F. Zielger, and M. McCarthy. 2006. Brain CD8 + and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. J. Neurovirol. 12: 272-283.
9. Peluso, R., A. Haase, L. Stowring, M. Edwards, and P. Ventura. 1985. ATrojan Horse mechanism for the spread of visna virus in monocytes. Virology 147: 231-236.
10. Sadagopal, S., R. R. Amara, S. Kannanganat, S. Sharma, L. Chennareddi, and H. L. Robinson. 2008. Expansion and exhaustion of T-cell responses during mutational escape from long-term viral control in two DNA/modified vaccinia virus Ankara-vaccinated and simian-human immunodeficiency virus SHIV- 89.6P-challenged macaques. J. Virol. 82: 4149-4153.
11. + T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapynaive HIV-positive subjects. J. Virol. 82: 10418-10428.
12. von Herrath, M., M. B. Oldstone, and H. S. Fox. 1995. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J. Immunol. 154: 5582-5589.
13. Nolz, J. C., G. R. Starbeck-Miller, and J. T. Harty. 2011. Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions. Immunotherapy 3: 1223-1233.
14. Zloza, A., and L. Al-Harthi. 2006. Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual consideration. J. Leukoc. Biol. 79: 4-6.
15. + T cells that coexpresses CD4 on its surface. Blood 114: 3841-3853.
16. + T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood 102: 2156-2164.
17. + T cells. Immunology 103: 270-280.
18. + T cells. J. Immunol. 185: 2013-2019.
19. Yang, L. P., J. L. Riley, R. G. Carroll, C. H. June, J. Hoxie, B. K. Patterson, Y. Ohshima, R. J. Hodes, and G. Delespesse. 1998. Productive infection of neonatal CD8+ T lymphocytes by HIV-1. J. Exp. Med. 187: 1139-1144.
20. Kitchen, S. G., N. R. Jones, S. LaForge, J. K. Whitmire, B. A. Vu, Z. Galic, D. G. Brooks, S. J. Brown, C. M. Kitchen, and J. A. Zack. 2004. CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. Proc. Natl. Acad. Sci. USA 101: 8727-8732.
21. Kitchen, S. G., Y. D. Korin, M. D. Roth, A. Landay, and J. A. Zack. 1998. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J. Virol. 72: 9054-9060.
22. Kitchen, S. G., S. LaForge, V. P. Patel, C. M. Kitchen, M. C. Miceli, and J. A. Zack. 2002. Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor. Blood 99: 207-212.
23. Kitchen, S. G., J. K. Whitmire, N. R. Jones, Z. Galic, C. M. Kitchen, R. Ahmed, and J. A. Zack. 2005. The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens. Proc. Natl. Acad. Sci. USA 102: 3794-3799.
24. Ortolani, C., E. Forti, E. Radin, R. Cibin, and A. Cossarizza. 1993. Cytofluorimetric identification of two populations of double positive (CD4+, CD8+) T lymphocytes in human peripheral blood. Biochem. Biophys. Res. Commun. 191: 601-609.
25. Blue, M. L., J. F. Daley, H. Levine, and S. F. Schlossman. 1985. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J. Immunol. 134: 2281-2286.
26. Flamand, L., R. W. Crowley, P. Lusso, S. Colombini-Hatch, D. M. Margolis, and R. C. Gallo. 1998. Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc. Natl. Acad. Sci. USA 95: 3111-3116.
27. Richards, M. H., S. D. Narasipura, S. Kim, M. S. Seaton, V. Lutgen, and L. Al-Harthi. 2015. Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDS. Glia 63: 441-451.
28. Polakis, P. 2007. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17: 45-51.
29. Angers, S., and R. T. Moon. 2009. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10: 468-477.
30. Coombs, G. S., T. M. Covey, and D. M. Virshup. 2008. Wnt signaling in development, disease and translational medicine. Curr. Drug Targets 9: 513-531.
31. Henderson, L. J., A. Sharma, M. C. G. Monaco, E. O. Major, and L. Al-Harthi. 2012. Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/b-catenin signaling in astrocytes: relevance to HIV neuropathogenesis. J. Neurosci. 32: 16306-16313.
32. Richards, M. H., M. S. Seaton, J. Wallace, and L. Al-Harthi. 2014. Porcupine is not required for the production of the majority of Wnts from primary human astrocytes and CD8+ T cells. PLoS One 9: e92159.
33. Dash, P. K., H. E. Gendelman, U. Roy, S. Balkundi, Y. Alnouti, R. L. Mosley, H. A. Gelbard, J. McMillan, S. Gorantla, and L. Y. Poluektova. 2012. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. AIDS 26: 2135-2144.
34. Boska, M. D., P. K. Dash, J. Knibbe, A. A. Epstein, S. P. Akhter, N. Fields, R. High, E. Makarov, S. Bonasera, H. A. Gelbard, et al. 2014. Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice. Mol. Neurodegener. 9: 58.
35. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
36. Shacklett, B. L., C. A. Cox, D. T. Wilkens, R. Karl Karlsson, A. Nilsson, D. F. Nixon, and R. W. Price. 2004. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J. Infect. Dis. 189: 2202-2212.
37. Lee, S. A., E. Sinclair, H. Hatano, P. Y. Hsue, L. Epling, F. M. Hecht, D. R. Bangsberg, J. N. Martin, J. M. McCune, S. G. Deeks, and P. W. Hunt. 2014. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One 9: e89444.
38. Effros, R. B. 2003. Replicative senescence: the final stage of memory T cell differentiation? Curr. HIV Res. 1: 153-165.
39. Northfield, J.W., C. P. Loo, J. D. Barbour, G. Spotts, F. M. Hecht, P. Klenerman, D. F. Nixon, and J. Michælsson. 2007. Human immunodeficiency virus type 1 (HIV-1)- specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J. Virol. 81: 5759-5765.
40. Hersperger, A. R., J. N. Martin, L. Y. Shin, P. M. Sheth, C. M. Kovacs, G. L. Cosma, G. Makedonas, F. Pereyra, B. D. Walker, R. Kaul, et al. 2011. Increased HIV-specific CD8+ T-cell cytotoxic potential in HIVelite controllers is associated with T-bet expression. Blood 117: 3799-3808.
41. Lieberman, J., L. A. Trimble, R. S. Friedman, J. Lisziewicz, F. Lori, P. Shankar, and H. Jessen. 1999. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. AIDS 13: 891-899.
42. Dock, J. N., and R. B. Effros. 2011. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis. 2: 382-397.
43. Valcour, V., T. Chalermchai, N. Sailasuta, M. Marovich, S. Lerdlum, D. Suttichom, N. C. Suwanwela, L. Jagodzinski, N. Michæl, S. Spudich, et al; RV254/SEARCH 010 Study Group. 2012. Central nervous system viral invasion and inflammation during acute HIV infection. J. Infect. Dis. 206: 275-282.
44. Kumar, A., A. Zloza, R. T. Moon, J. Watts, A. R. Tenorio, and L. Al-Harthi. 2008. Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J. Virol. 82: 2813-2820.
45. Xie, H., Z. Huang, M. S. Sadim, and Z. Sun. 2005. Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL. J. Immunol. 175: 7981-7988.
46. Gattinoni, L., E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290-1297.
47. +memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection. J. Virol. 88: 13836-13844.
48. Henson, S. M., N. E. Riddell, and A. N. Akbar. 2012. Properties of end-stage human T cells defined by CD45RA re-expression. Curr. Opin. Immunol. 24: 476-481.
49. Lanzavecchia, A., and F. Sallusto. 2005. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17: 326-332.
50. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
51. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
52. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106-111.
53. Meyer-Olson, D., B. C. Simons, J. A. Conrad, R. M. Smith, L. Barnett, S. L. Lorey, C. B. Duncan, R. Ramalingam, and S. A. Kalams. 2010. Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo. Blood 116: 396-405.
54. Schrier, R. D., S. Hong, M. Crescini, R. Ellis, J. Pérez-Santiago, C. Spina, and S. Letendre, HNRP Group. 2015. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND). PLoS One 10: e0116526.